ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹-2,268 Cr | ₹-2,314 Cr | ₹-2,314 Cr | ₹-1,914 Cr | ₹-1,870 Cr |
What is the latest Profit & Loss Account Balance ratio of ORCHID PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2023 | ₹-2,268 Cr |
Mar2022 | ₹-2,314 Cr |
Mar2021 | ₹-2,314 Cr |
Mar2020 | ₹-1,914 Cr |
Mar2019 | ₹-1,870 Cr |
How is Profit & Loss Account Balance of ORCHID PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2023 | ₹-2,268 Cr | Negative | |
Mar2022 | ₹-2,314 Cr | Negative | |
Mar2021 | ₹-2,314 Cr | Negative | |
Mar2020 | ₹-1,914 Cr | Negative | |
Mar2019 | ₹-1,870 Cr | - |
Compare Profit & Loss Account Balance of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹5,204.6 Cr | -4.4% | -3.4% | 160.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -4.4% |
-3.4% |
160.5% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses